Morgan Stanley Maintains Overweight on Arxis, Raises Price Target to $66

Benzinga · 2d ago
Morgan Stanley analyst Kristine Liwag maintains Arxis (NASDAQ:ARXS) with a Overweight and raises the price target from $62 to $66.